Abstract:Background Microsatellite instability in colon cancer implies favorable therapeutic outcomes after checkpoint blockade immunotherapy. However, the molecular nature of microsatellite instability is not well elucidated. Methods We examined the immune microenvironment of colon cancer using assessments of the bulk transcriptome and the single-cell transcriptome focusing on molecular nature of microsatellite stability (MSS) and microsatellite instability (MSI) in colorectal cancer from a public database. The association of the mutation pattern and microsatellite status was analyzed by a random forest algorithm in The Cancer Genome Atlas (TCGA) and validated by our in-house dataset (39 tumor mutational burden (TMB)-low MSS colon cancer, 10 TMB-high MSS colon cancer, 15 MSI colon cancer). A prognostic model was constructed to predict the survival potential and stratify microsatellite status by a neural network. Results Despite the hostile CD8 + cytotoxic T lymphocyte (CTL)/Th1 microenvironment in MSI colon cancer, a high percentage of exhausted CD8 + T cells and upregulated expression of immune checkpoints were identified in MSI colon cancer at the single-cell level, indicating the potential neutralizing effect of cytotoxic T-cell activity by exhausted T-cell status. A more homogeneous highly expressed pattern of PD1 was observed in CD8 + T cells from MSI colon cancer; however, a small subgroup of CD8 + T cells with high expression of checkpoint molecules was identified in MSS patients. A random forest algorithm predicted important mutations that were associated with MSI status in the TCGA colon cancer cohort, and our in-house cohort validated higher frequencies of BRAF , ARID1A , RNF43 , and KM2B mutations in MSI colon cancer. A robust microsatellite status–related gene signature was built to predict the prognosis and differentiate between MSI and MSS tumors. A neural network using the expression profile of the microsatellite status–related gene signature was constructed. A receiver operating characteristic curve was used to evaluate the accuracy rate of neural network, reaching 100%. Conclusion Our analysis unraveled the difference in the molecular nature and genomic variance in MSI and MSS colon cancer. The microsatellite status–related gene signature is better at predicting the prognosis of patients with colon cancer and response to the combination of immune checkpoint inhibitor–based immunotherapy and anti-VEGF therapy.

Microsatellite Instability: a Review of What the Oncologist Should Know

The Clinical Significance of Microsatellite Instability in Precision Treatment

Microsatellite instability: A 2024 update

Current Microsatellite Instability Testing in Management of Colorectal Cancer

Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.

Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms

Microsatellite instability status differentially associates with intratumoral immune microenvironment in human cancers

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency

Microsatellite instability and chemosensitivity in solid tumours

Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review

Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study

Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer

Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair

Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency Between PCR and IHC

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy

Microsatellite instability states serve as predictive biomarkers for tumors chemotherapy sensitivity

Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment

Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer

Microsatellite instability in gastric cancer: molecular features and clinical implications

Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer

An Exploration of Gastric Cancer with Heterogeneous Mismatch Repair Status.